| 名前 | 業界 | 共有, % | P/BV | P/S | P/E | EV/Ebitda | 配当利回り |
|---|---|---|---|---|---|---|---|
| Mind Medicine (MindMed) Inc. | Healthcare | 13.7652 | 1.94 | 0 | 0 | -0.7272 | 0 |
 COMPASS Pathways plc |
Healthcare | 6.71965 | 2 | 0 | 0 | -1.92 | 0 |
 Relmada Therapeutics, Inc. |
Healthcare | 5.08039 | 1.08 | 0 | 0 | -0.8487 | 0 |
 Alkermes plc |
Healthcare | 4.99899 | 3.32 | 3.13 | 13.27 | 11.06 | 0 |
 Intra-Cellular Therapies, Inc. |
Healthcare | 4.59804 | 7.5 | 12.65 | 0 | -71.28 | 0 |
 Atai Life Sciences N.V. |
Healthcare | 4.32468 | 1.83 | 691.6 | 0 | -1.4 | 0 |
| GH Research PLC | Healthcare | 4.2406 | 2.04 | 0 | 0 | -5.09 | 0 |
 Sage Therapeutics, Inc. |
Healthcare | 3.69571 | 0.7095 | 8 | 2.85 | -0.6031 | 0 |
| Greenbrook TMS Inc. | Healthcare | 0.20913 | 0 | 0 | 0 | 0 | 0 |
| 47.64 | 2.27 | 79.49 | 1.79 | -7.87 | 0 |
AdvisorShares Psychedelics ETF
半年間の収益性: 54.1%
業界: Health & Biotech Equities
サブスクリプションの料金を支払う
サブスクリプションにより、企業およびポートフォリオ分析のためのより多くの機能とデータを利用できます
